CTC researchers and their collaborators have a strong record of published research in prestigious international journals. Recent journal articles are listed here.
Use the search link below to find specific articles, or articles by year, author, trial or group, back to 2005.
Search for articles
Askie LM. Optimal oxygen saturations in preterm infants: a moving target. Current Opinion in Pediatrics 2013;
Barz T, Lange J, Melloh M, Staub L, Merk HR, Klöting I, Follak N. Histomorphometric and radiographical changes after lumbar implantation of the PEEK nonfusion interspinous device in the BB.4S rat model. Spine 2013; 38 (5) :E263–E269.
Brakoulias V, Starcevic V, Berle D, Milicevic D, Moses K, Hannan A, Sammut P, Martin A. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder. Australasian Psychiatry 2013;
Brighton TA, Eikelboom JW, Simes J. Aspirin for preventing venous thromboembolism [commentary]. New England Journal of Medicine 2013; 368 (8) :773.
Callander E, Schofield DJ. The relationship between employment and social participation among Australians with a disabling chronic health condition: a cross-sectional analysis. BMJ Open 2013; 3 (1) :e002054.
Chan KH, O'Connell RL, Sullivan DR, Hoffmann LS, Rajamani K, Whiting M, Donoghoe MW, Vanhala M, Hamer A, Yu B, Stocker R, Ng MK, Keech AC, on behalf of the FIELD study investigators. Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 2013;
Chen, Hu, Lin, Jenkins, Keech, Mott, Lyons, Ma. Therapeutic effects of PPAR. Diabetes 2013; 62 (1) :261–272.
Cholesterol Treatment Trialist (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials [abstract]. Journal of Vascular Surgery 2013; 57 (1) :284.
Dietz HP, Nazemian K, Shek KL, Martin A. Can urodynamic stress incontinence be diagnosed by ultrasound?. International Urogynecology Journal 2013;
Fox PN, Chatfield MD, Beith JM, Allison S, Della-Fiorentina S, Fisher D, Turley K, Grimison PS. Factors delaying chemotherapy for breast cancer in four urban and rural oncology units. ANZ Journal of Surgery 2013;
Fuller NR, Colagiuri S, Schofield D, Olson AD, Shrestha R, Holzapfel C, Wolfenstetter SB, Holle R, Ahern AL, Hauner H, Jebb SA, Caterson ID. A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care-an international randomised controlled trial. International Journal of Obesity 2013;
Grimison P, Phillips F, Butow P, White K, Yip D, Sardelic F, Underhill C, Tse R, Simes R, Turley K, Raymond C, Goldstein D. Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals. Asia-Pacific Journal of Clinical Oncology 2013;
Hankey GJ, Anderson NE, Ting RD, Veillard AS, Romo M, Wosik M, Sullivan DR, O'Connell RL, Hunt D, Keech AC. Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. Journal of Neurology, Neurosurgery, and Psychiatry 2013;
Hardikar AA, Walker MD, Lynn F. Noncoding RNAs. Experimental Diabetes Research 2013;
Herrmann M, Whiting MJ, Veillard AS, Ehnholm C, Sullivan DR, Keech AC. Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 2013; 50 (12) :2213–2219.
Hong A, Jones D, Chatfield M, Soon Lee C, Zhang M, Clark J, Elliott M, Harnett G, Milross C, Rose B. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results. Annals of Surgical Oncology 2013;
Hong AM, Martin A, Armstrong BK, Lee CS, Jones D, Chatfield MD, Zhang M, Harnett G, Clark J, Elliott M, Milross C, Smee R, Corry J, Liu C, Porceddu S, Vaska K, Veness M, Morgan G, Fogarty G, Veivers D, Rees G, Rose B. Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology 2013; 24 (1) :215–219.
Hong AM, Martin A, Chatfield M, Jones D, Zhang M, Armstrong B, Lee CS, Harnett G, Milross C, Clark J, Elliott M, Smee R, Corry J, Liu C, Porceddu S, Rees G, Rose B. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer 2013;
Hong, Zhang, Veillard, Jahanbani, Lee, Jones, Harnett, Clark, Elliott, Milross, Rose. The prognostic significance of hypoxia inducing factor 1-. Oral Oncology 2013;
Houghton BB, Chalasani V, Hayne D, Grimison P, Brown CSB, Patel MI, Davis ID, Stockler MR. Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International 2013;
Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clinical Lung Cancer 2013; 4 (1) :70–77.
Kao SC, Vardy J, Harvie R, Chatfield M, van Zandwijk N, Clarke S, Pavlakis N. Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer 2013;
Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR. Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Supportive Care in Cancer 2013; 21 (2) :369–376.
Lee CK, Simes RJ, Brown C, Gebski V, Pfisterer J, Swart AM, Berton-Rigaud D, Plante M, Skeie-Jensen T, Vergote I, Schauer C, Pisano C, Parma G, Baumann K, Ledermann JA, Pujade-Lauraine E, Bentley J, Kristensen G, Belau A, Nankivell M, Canzler U, Lord SJ, Kurzeder C, Friedlander M. A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer. Annals of Oncology 2013;
McCaughan GJ, Blinman PL, Boyer MJ, Stockler MR. Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small cell lung cancer.. Internal Medicine Journal 2013;
Moran PS, O'Neill M, Teljeur C, Flattery M, Murphy LA, Smith G, Ryan M. Robot-assisted radical prostatectomy compared with open and laparoscopic approaches: a systematic review and meta-analysis. International Journal of Urology 2013;
Najim M, Cross S, Gebski V, Palme CE, Morgan GJ, Veness MJ. Early-stage squamous cell carcinoma of the lip: the Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head & Neck 2013;
Olver IN, Grimison P, Chatfield M, Stockler MR, Toner GC, Gebski V, Harrup R, Underhill C, Kichenadasse G, Singhal N, Davis ID, Boland A, McDonald A, Thomson D, for the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Supportive Care in Cancer 2013;
Olver IN, Keech AC. Forming networks for research: proposal for an Australian clinical trials alliance. Medical Journal of Australia 2013; 198 (5) :254–255.
O'Neill M, Moran PS, Teljeur C, O'Sullivan OE, O'Reilly BA, Hewitt M, Flattery M, Ryan M . Robot-assisted hysterectomy compared to open and laparoscopic approaches: systematic review and meta-analysis. Archives of Gynecology and Obstetrics 2013;
Pit SW, Shrestha R, Schofield D, Passey M. Partial and complete retirement due to ill-health among mature age Australians. Public Health 2013;
Saner M, Stoklosa A. Commercial, societal and administrative benefits from the analysis and clarification of definitions: the case of nanomaterials. Creativity and Innovation Management 2013; 22 (1) :26–36.
Schofield DJ, Callander EJ, Shrestha RN, Passey ME, Percival R, Kelly SJ. The indirect economic impacts of co-morbidities on people with depression. Journal of Psychiatric Research 2013;
Schofield DJ, Callander EJ, Shrestha RN, Percival R, Kelly SJ, Passey ME. The association between labour force participation and being in income poverty amongst those with mental health problems. Aging & Mental Health 2013; 17 (2) :250–257.
Schofield DJ, Shrestha RN, Percival R, Passey ME, Callander EJ, Kelly SJ. The personal and national costs of lost labour force participation due to arthritis: an economic study. BMC Public Health 2013;
Simes RJ, Webb SAR. Sustaining Australian research through clinical trials and investigator networks. Medical Journal of Australia 2013; 198 (3) :127–128.
Small K, Kelly C, Beldham-Collins R, Gebski V. Whole breast and excision cavity radiotherapy plan comparison: conformal radiotherapy with sequential boost versus intensity-modulated radiation therapy with a simultaneously integrated boost. Medical Radiation Sciences 2013; 60 (1) :16–24.
Spina R, Chu SY, Chatfield M, Chen J, Tin MM, Boyer M. Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer. Internal Medicine Journal 2013;
Stark D, Nankivell M, Pujade-Lauraine E, Kristensen G, Elit L, Stockler M, Hilpert F, Cervantes A, Brown J, Lanceley A, Velikova G, Sabate E, Pfisterer J, Carey MS, Beale P, Qian W, Swart AM, Oza A, Perren T. Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Oncology 2013;
Stockler MR. Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer. Annals of Internal Medicine 2013; 158 (2) :JC9.
Tarnow-Mordi W, Simes J, Cruz M. Strategies to accelerate recruitment to NHMRC multi-centre clinical trials. Journal of Paediatrics and Child Health 2013; 49 (1) :E103–195.
Taylor CJ, Satoor SN, Ranjan AK, Pereira E, Cotta MV, Joglekar MV. A protocol for measurement of noncoding RNA in human serum. Experimental Diabetes Research 2013;
Tebbutt NC, Parry MM, Zannino D, Strickland AH, Van Hazel GA, Pavlakis N, Ganju V, Mellor D, Dobrovic A, Gebski VJ, on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG). Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial. British Journal of Cancer 2013; 108 (4) :771–774.
Vickers MM, Karapetis CS, Tu D, O'Callaghan CJ, Price TJ, Tebbutt NC, Van Hazel G, Shapiro JD, Pavlakis N, Gibbs P, Blondal J, Lee U, Meharchand JM, Burkes RL, Rubin SH, Simes J, Zalcberg JR, Moore MJ, Zhu L, Jonker DJ. Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17. Annals of Oncology 2013; 24 (4) :953–960.
Wang AY, Palme CE, Wang JT, Morgan GJ, Gebski V, Gilchrist J, Veness MJ. Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck. Journal of Laryngology and Otology 2013;
Wang JT, Palme CE, Wang AY, Morgan GJ, Gebski V, Veness MJ. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. Journal of Laryngology and Otology 2013; 127 (Suppl. 1) :S2–7.
